Milena Bond

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Particulate Matter

Rheumatoid Arthritis Patients

Top Venues

Annals of the rheumatic diseases

Arthritis care & research

Nature reviews. Rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Frank Buttgereit, Andriko Palmowski, Milena Bond, Giovanni Adami, Christian Dejaco
Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases. Nature reviews. Rheumatology (2024)
Milena Bond, Alessandro Tomelleri, Maria A Reatini, Campochiaro Corrado, Giorgio Cattani, Lorenzo Dagna, Maurizio Rossini, Christian Dejaco, Giovanni Adami
Impact of Exposure to Environmental Particulate Matter on the Onset of Giant Cell Arteritis. Arthritis care & research (2024)
Frank Buttgereit, Andriko Palmowski, Milena Bond, Giovanni Adami, Christian Dejaco
Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases. Nature reviews. Rheumatology 20 (7) (2024)
Milena Bond, Alessandro Tomelleri, Maria A Reatini, Campochiaro Corrado, Giorgio Cattani, Lorenzo Dagna, Maurizio Rossini, Christian Dejaco, Giovanni Adami
Impact of exposure to environmental particulate matter on the onset of giant cell arteritis. Arthritis care & research (2024)
Catalina Sanchez-Alvarez, Milena Bond, Medha Soowamber, Dario Camellino, Melanie A Anderson, Carol A Langford, Christian Dejaco, Zahi Touma, Josef S Smolen
Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task force. RMD open 9 (2) (2023)
Milena Bond, Christian Dejaco
Polymyalgia rheumatica: crafting the future of a simple (but not easy!) clinical syndrome. Annals of the rheumatic diseases (2023)
Christian Dejaco, Andreas Kerschbaumer, Daniel Aletaha, Milena Bond, Elvis Hysa, Dario Camellino, Lisa Ehlers, Andy Abril, Simone Appenzeller, Maria Cinta Cid, Bhaskar Dasgupta, Christina Duftner, Peter C Grayson, Bernhard Hellmich, Alojzija Hocevar, Tanaz A Kermani, Eric L Matteson, Susan P Mollan, Lorna Neill, Cristina Ponte, Carlo Salvarani, Sebastian Eduardo Sattui, Wolfgang Andreas Schmidt, Philip Seo, Josef S Smolen, Jens Thiel, Carlos Enrique Toro Gutiérrez, Madeline Whitlock, Frank Buttgereit
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica. Annals of the rheumatic diseases (2023)
Catalina Sanchez-Alvarez, Milena Bond, Medha Soowamber, Dario Camellino, Melanie A Anderson, Carol A Langford, Christian Dejaco, Zahi Touma, Josef S Smolen
Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task force. RMD open 9 (2) (2023)
Philipp Bosch, Milena Bond, Christian Dejaco, Cristina Ponte, Sarah Louise Mackie, Louise Falzon, Wolfgang Andreas Schmidt, Josef S Smolen
Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations. RMD open 9 (3) (2023)
Christian Dejaco, Josef S Smolen, Milena Bond, Philipp Bosch, Cristina Ponte, Sarah Louise Mackie, Thorsten A Bley, Daniel Blockmans, Sara Brolin, Ertuğrul Çağri Bölek, Rebecca Cassie, Maria Cinta Cid, Juan Molina Collada, Bhaskar Dasgupta, Berit Dalsgaard Nielsen, Eugenio de Miguel, Rafi Haner Direskeneli, Christina Duftner, Alojzija Hocevar, Anna Moltó, Valentin Sebastian Schäfer, Luca Seitz, Riemer H J A Slart, Wolfgang Andreas Schmidt
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update. Annals of the rheumatic diseases (2023)
Milena Bond, Alessandro Tomelleri, Frank Buttgereit, Eric L Matteson, Christian Dejaco
Looking ahead: giant-cell arteritis in 10 years time. Therapeutic advances in musculoskeletal disease 14 (2022)